<--- Back to Details
First PageDocument Content
Clinical trials / Organic chemistry / Endocrine disruptors / Dose-ranging study / Malathion / Methadone / Maximum tolerated dose / Regulatory requirement / Dose / Toxicology / Chemistry / Medicine
Date: 2013-07-12 14:26:10
Clinical trials
Organic chemistry
Endocrine disruptors
Dose-ranging study
Malathion
Methadone
Maximum tolerated dose
Regulatory requirement
Dose
Toxicology
Chemistry
Medicine

S1C: Dose Selection for Carcinogenicity Studies of Pharmaceuticals

Add to Reading List

Source URL: www.hc-sc.gc.ca

Download Document from Source Website

File Size: 35,14 KB

Share Document on Facebook

Similar Documents

Microsoft Word - Joint Advisory Opinion by the BME BON and BOP regarding Methadone Clinics

DocID: 1varW - View Document

Methadone Dosing Guideline

DocID: 1v2ad - View Document

Methadone Treatment and Services Advisory Committee Final Report June 9, 2016

DocID: 1t4Ca - View Document

Overdose Prevention Overdoses from opioid drugs (drugs like heroin, methadone, morphine, and fentanyl) have been on the rise in B.C. Opioid overdoses are very serious and can result in death. If you or someone you know i

DocID: 1sUWu - View Document

INSTRUCTIONS TO COMMENT DATES: To be assured consideration, comments must be received at one of the ADDRESSES provided below, no later than 5 p.m. on Monday, April 11, 2016. In commenting, please refer to file code SAMHS

DocID: 1si22 - View Document